Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy - Nagu, Tumaini; Aboud, Said; Rao, Martin; Matee, Mecky; Axelsson, Rebecca; Valentini, Davide; Mugusi, Ferdinand; Zumla, Alimuddin; Maeurer, Markus (International journal of infectious diseases, 2017)
Keywords: Adult; Antitubercular Agents - pharmacology; Antitubercular Agents - therapeutic use; cellular immune response; CMV; Cytomegalovirus - immunology; EBV; Female; Herpesvirus 4, Human - immunology; Humans; IFN-γ; Immunity, Cellular - immunology; Infectious Disease; Male; Predictive Value of Tests; pulmonary tuberculosis; Pulmonary/Respiratory; survival; TB therapy; Treatment Outcome; Tuberculosis Vaccines - immunology; Tuberculosis, Pulmonary - drug therapy; Tuberculosis, Pulmonary - immunology; Tuberculosis, Pulmonary - mortality; pulmonary tuberculosis; cellular immune response; IFN-γ; TB therapy; survival; EBV; CMV